Market revenue in 2023 | USD 332.1 million |
Market revenue in 2030 | USD 891.1 million |
Growth rate | 15.1% (CAGR from 2023 to 2030) |
Largest segment | Tavr (transcatheter aortic valve replacement) |
Fastest growing segment | LAAC (Left Atrial Appendage Closure) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | SAVR (Surgical Aortic Valve Replacement), TAVR (Transcatheter Aortic Valve Replacement), Mitral Repair (Annuloplasty), LAAC (Left Atrial Appendage Closure) |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Edwards Lifesciences Corp, Abbott Laboratories, St. Jude Medical, LivaNova PLC, Stryker Corp, Lepu Medical, Biomerics, CardioKinetix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to structural heart devices market will help companies and investors design strategic landscapes.
Tavr (transcatheter aortic valve replacement) was the largest segment with a revenue share of 54.95% in 2023. Horizon Databook has segmented the Spain structural heart devices market based on savr (surgical aortic valve replacement), tavr (transcatheter aortic valve replacement), mitral repair (annuloplasty), laac (left atrial appendage closure) covering the revenue growth of each sub-segment from 2018 to 2030.
The structural heart devices market in Spain is witnessing notable growth, propelled by several key factors. One significant driver is Spain's aging population, with a considerable portion experiencing CVDs such as valvular disorders and heart failure. Recent data highlights the prevalence of CVDs in Spain, with ischemic heart disease alone accounting for a significant proportion of mortality rates.
In addition, advancements in medical technology and increasing awareness among healthcare professionals and patients about the benefits of structural heart devices have contributed to the market's expansion.
The emergence of minimally invasive procedures and the adoption of cutting-edge technologies have enhanced patient outcomes and reduced treatment-related complications, driving the demand for structural heart devices across the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain structural heart devices market , including forecasts for subscribers. This country databook contains high-level insights into Spain structural heart devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account